➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Dow
AstraZeneca
McKinsey
Harvard Business School

Last Updated: August 11, 2020

DrugPatentWatch Database Preview

Inventia Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for INVENTIA, and what generic and branded alternatives to INVENTIA drugs are available?

INVENTIA has eleven approved drugs.



Summary for Inventia
US Patents:0
Tradenames:11
Ingredients:11
NDAs:11
Patent Litigation for Inventia: See patent lawsuits for Inventia

Drugs and US Patents for Inventia

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Inventia ILOPERIDONE iloperidone TABLET;ORAL 207231-003 Nov 28, 2016 DISCN No No   Start Trial   Start Trial
Inventia PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE;ORAL 204452-003 Jun 12, 2019 AB RX No No   Start Trial   Start Trial
Inventia Hlthcare BUSPIRONE HYDROCHLORIDE buspirone hydrochloride TABLET;ORAL 209696-001 May 3, 2018 AB RX No No   Start Trial   Start Trial
Inventia Hlthcare TOLTERODINE TARTRATE tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 204562-002 Aug 19, 2019 AB RX No No   Start Trial   Start Trial
Inventia OLMESARTAN MEDOXOMIL olmesartan medoxomil TABLET;ORAL 208659-001 May 18, 2020 AB RX No No   Start Trial   Start Trial
Inventia ILOPERIDONE iloperidone TABLET;ORAL 207231-005 Nov 28, 2016 DISCN No No   Start Trial   Start Trial
Inventia LANSOPRAZOLE lansoprazole CAPSULE, DELAYED REL PELLETS;ORAL 205868-002 Aug 30, 2017 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Baxter
Colorcon
AstraZeneca
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.